ACTION DUCHENNE INTERNATIONAL CONFERENCE

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

Treatment and Management here and Now DMD Katie Bushby, Michelle Eagle, Robert Bullock, Mike Gibson, John Bourke Newcastle upon Tyne Muscle Centre.
2012 UPDATE. What guidelines do we have available to follow for asthma 1) Asthma GP monitoring Guideline 2) Asthma Diagnosis Guideline 3) Acute asthma.
Lifespan changes in sleep. 1. EEG (Electro-encephalograph) This is used to measure electrical activity in the brain This is used to measure electrical.
Duchenne Muscular Dystrophy Sherri Garcia Muscular Dystrophy: Walk a Mile in Their Shoes CDC’s 2005 Science Ambassador Program.
Comprehensive Review of Positioning in Long - Term - Care
Chapter3 Problems of the neonate and young infant - Neonatal resuscitation.
Duchenne Muscular Dystrophy: Orthopaedic Management.
Duchenne Muscular Dystrophy: Considerations for Surgery.
TURNER sYNDROME By: Jazmin Barnes.
2 Influences on Cardiorespiratory Endurance Fitness experts generally measure cardiorespiratory endurance in terms of maximal oxygen consumption, or VO.
Duchenne Muscular Dystrophy
Philip Ord Isaac Lalich DUCHENNE MUSCULAR DYSTROPHY (DMD)
D UCHENNE ’ S M USCULAR D YSTROPHY Kate Chipchase Vts teaching Feb 2012 ST2.
MUSCULAR DYSTROPHY By Jasmine DeLong. INHERITANCE Muscular dystrophy is a hereditary condition marked by progressive weakening and wasting of the muscles.
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Applied Epidemiology Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) By Chris Callan 23 April 2008.
Injectable Opioid Treatment in England Clinical Experience Rob van der Waal.
Duchenne Muscular Dystrophy
Human Genetic disorders
Drug Therapy.  Although the causes of schizophrenia are still largely unknown, treatment for it focuses on lessening the type one and type two symptoms.
Commonly referred to as DMD The disease was first described by the Neapolitan physician Giovanni Semmola in 1834 and Gaetano Conte in 1836 DMD is named.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
Maintaining a Healthy Weight 1.Describe how heredity and lifestyle effect body weight. 2.Summarize the components of a healthy weight management plan.
Clinical Pharmacology of Corticosteroids
Duchenne Muscular Dystrophy: Cardiac Management. Introduction Aim: early detection and treatment of deterioration in heart muscle function Cardiac disease.
Osteogenesis imperfecta
By: Logan Gillings, Reyes E. Cause Of Disease  Is a genetic disorder that causes progressive muscle weakness as individual muscle cells die.  An absence.
M USCULAR D YSTROPHY By: Collin Lowe. C AUSES Muscular Dystrophy is inherited in an X-linked recessive pattern, meaning that the mutated gene that causes.
Duchenne Muscular Dystrophy
Case #13 Ellen Marie de los Reyes March 15, 2007.
(DMD) Duchenne Muscular Dystrophy. History of DMD It was first described by a french neurologist named Guillaume Benjamin Amand Duchenne in Previous.
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
Common Facts 4 DMD is a recessive, genetic disorder Most common X chromosome linked disorder Disorder of the motor neuron, neuromuscular.
Scottish Muscle Network AHP study day 20 th April 2015 Karen Naismith.
Skeletal and Muscular. Brittni Parrish..
Nutritional issues for children with asthma. High Incidence Rate Among: Males Low socioeconomic status African Americans Family history of asthma or allergies.
Falls prevention in care homes and at home Dr Raymond F Jankowski.
Adults and aged athletes. Adult and aged athletes The most obvious concern for adult and aged athletes is pre-existing health risks. An older person who.
Duchenne Muscular Dystrophy: Emergency Care Considerations.
Rheumatoid Arthritis Dr Chandini Rao Consultant Rheumatologist.
Targeting Inflammation in Duchenne Muscular Dystrophy: Non-mutation specific approaches in developing therapies for DMD Joanne M. Donovan, M.D., Ph.D.
Health Benefits of Exercise for Frailer Older People
VBP15 in Duchenne muscular dystrophy
Diabetes  23.6 million people have diabetes  7.8% of population  1.6 million people ages 20 or older were diagnosed with diabetes in  All of.
DISEASE ASSOCIATED WITH MUSCLES IN CHILDHOOD MUSCULAR DYSTROPHY.
Immunisation Part2 Schedule (part 1) Reason for doing it (part 2) Why some don’t do it. (part 2)
PHYSICAL ACTIVITY HELPS… PHYSICAL WELL BEING Related to your heart, lungs and body systems growing strong and healthy Your body shape improves (looking.
Weaning A Dog Off Of Prednisone Due To Ibd Deltasone Price prednisone for treatment of fibromyalgia can prednisone cause sore tongue prednisone for dogs.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
Case study Which antidepressant Dr. Matthew Miller.
Duchenne Muscular Dystrophy By: Callia Ricozzi. What is Muscular Dystrophy?  The deterioration of the muscles  Dystrophin not made  gene mutation 
Research and Development Name: Julie Long Student Number: C Course Code: DT204.2.
Takinf 7.5 Of Prednisone In Elderly Women Buy Cheap Deltasone side effects prednisone 20mg does prednisone treat eczema how long before prednisone works.
D uchenne M uscular D ystrophy - GENETICS - The Cause and Cure By: Chaz B.
Duchenne's Muscular Dystrophy By: Timothy Taggart & Mark Miville-Deschenes.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
Chapter ?? 23 Osteoporosis Nichols and Pavlovic C H A P T E R.
Azithromycin – for better or worse in chronic lung infection? Professor Emma Baker Professor of Clinical Pharmacology St George's, University of London.
What is muscular dystrophy? The muscular dystrophies (MD) are a group of genetic diseases characterized by progressive weakness and degeneration of the.
Prednisone Administration Buy Deltasone Online can prednisone cause puffy eyes prednisone 10mg arthritis what are the effects of prednisone on dogs adrenal.
Exondys 51™ - eteplirsen Manufacturer: Sarepta Therapeutics, Inc.
A Welsh Overview of Pharmacy and Falls Prevention
Genetics and its relation to neuromuscular diseases
ScOT-DMD SeCondary Osteoporosis & its Therapy in Duchenne Muscular Dystrophy (ScOT–DMD) Funded by CSO, Action Duchenne and Muscular Dystrophy UK.
Conditions in Occupational Therapy 5th edition Ben J
By: Kelli Novak & Katelyn Thompson
These PowerPoint slides reference FDA approval of new drugs for periodic paralysis, ALS, Duchenne muscular dystrophy, myasthenia gravis and spinal muscular.
Marina Di Marco Principal Neuromuscular Physiotherapist
Presentation transcript:

ACTION DUCHENNE INTERNATIONAL CONFERENCE 2015 Steroids in Duchenne muscular dystrophy The use of steroids in DMD. FOR-DMD steroid trial, does it still matter? Research update on steroids Dr Henriette van Ruiten Clinical Research Associate The John Walton Muscular Dystrophy Research Centre Newcastle upon Tyne

Duchenne Muscular Dystrophy (DMD) Affects 1 in 3500 newborns In UK, 100 boys are born with DMD each year There are 2500 patients with DMD Caused by mutation in the dystrophin gene, Absence of dystrophin in muscle fibres Clinically characterised by progressive muscle wasting

Current treatments Pharmacological treatments Treatment of complications Respiratory care Cardiac management Orthotic and orthopaedic approach The benefits of steroids in DMD were first suggested in 1974. Inconsistency of dosage was seen among and within different countries.

Pharmacological treatments Steroids Also called corticosteroids or glucocorticoids. Man made version of hormones normally produced by the adrenal glands Steroids are mainly used to reduce inflammation and suppress immune system Used in conditions such as asthma, arthritis, eczema etc) Why are steroids used in DMD? Only medication currently available for all which slows the decline in muscle strength in DMD

Steroids – history of use First report on steroids in DMD In 1974 Drachman et all. (Lancet) first prescribed steroids to 14 boys with DMD in USA. Recorded an improvement in motor power and muscular activities in 8 out of 14 boys. Steroids in the UK: Part of routine care in the last 15 years “Gold Standard” for treatment of DMD as per Standard of care guidelines (Bushby et al, 2009)

Steroids – which? Steroids used in DMD are prednisolone and deflazacort. Prednisolone Available in both tablet and liquid form Daily prednisolone more effective than intermittent in improving muscle strength (North Star data) Intermittent prednisolone has less side effects.

Steroids – which? Deflazacort: Only available in tablets Not available in all countries, more expensive Daily deflazacort is ? fewer side effects (weight gain) But more cataracts!

Steroids – which is best? No consensus which steroid regime is best Prednisone daily Deflazocort daily Prednisone 10 days on/10 days off Prednisone weekend doses Prednisone 10mg/kg (we)

Steroid – prescription chaos Worldwide 105 clinics which prescribe 29 different steroid regimes In the UK prednisolone is most commonly prescribed with 50:50 split between daily and intermittent regimes. Minority prescribe deflazacort. Current trial FOR DMD – to end the prescription chaos

FOR DMD STUDY (www.for-dmd.org) International study (US, Canada, UK, Germany, Italy) This study compares three ways of giving steroids to young boys (age 4-7) with DMD Steroids studied: Prednisolone daily 0.75mg/kg Prednisolone (0.75mg/kg) 10 days on/10 days off Deflazacort daily 0.9mg/kg Aim: to determine which increases muscle strength the most and which has the fewest side effects End date is September 2016

Steroids – balance between benefits and risk

Benefits of Steroids Early increase in motor skills and energy, Delay loss of milestones Boys on steroid are 5x more like to walk at age 12-17 than boys not on steroids (Treat NMD data) Improve upper arm function Important for feeding, driving wheelchair, self care and using phones/computers Stabilisez resp function – improves vital capcity Steroids strengthen axial muscles (delay spinal surgery) Data Treat NMD regustry: steroid users are 5x more liley to walk than non steroid users at age 12-17 Boys not on steroid slose ability to walk between age 9-10

Benefits of steroids Strengthen muscles in the back Reduces likelihood of spinal surgery from 90% to 10% Strengthen breathing muscles Steroids improve vital capacity (FVC) Low FVC linked to need for breathing support Protect the heart However, response to steroids is variable Approx 1-2% of boys do not respond to steroids ON steroid FVC continues to increase with age, Not on steroids it declines.

Side effects of steroids Considerable but predictable Side effects: Behaviour problems Weight gain Cushingoid appearance Vertebral fractures Immunosuppression Short stature Delayed puberty Cataracts Hypertension GI upset Are significant Require proactive management Behavioural guidance Prophylaxis/treatment of osteoporosis Regular follow up (BP, glycosuria, eye check, physical exam) Flue jabs Avoid live vaccines Short stature: Don’t advocate use of growth hormone Puberty delay – testosterone is very successful and GI upset: avoid ibuprofen

Starting steroids Around the plateau phase of motor function. This usually happens around the age of 4-5yrs old. With time steroid dose is adjusted according to benefits and side effects Try and prevent/treat side effects before reducing dose In older less ambulant boys steroids may still be of benefit; eg in improving upper body strength, reducing the risk of scoliosis and stabilizing respiratory function.

General advice on taking steroids Before taking steroids: check chickenpox immunity, bone scan and an eye check. Once the steroids have been started: regular review for monitoring of side effects, and a regular bone scan Do not stop steroids suddenly, must be reduced gradually.

Emergencies in boys with DMD on steroids If vomiting or unable to take steroids – contact GP or the muscle team. Your son may need to be given steroids by injection. Always carry your steroid warning card Information about emergency management for boys with DMD is available from AD (Action Emergency pack) and Parent Project (Emergency information card)

When to stop steroids The age to stop steroids needs to be decided individually. It may be necessary to change or stop the steroids because of side effects. In other situations, they can be used for many years, beyond the age at loss of ambulation. Never stop steroids suddenly! Message is not to stop stroids – benefots continu beyone loss of ambulation

Research update FOR DMD trial - update Recruitment target = 225 boys End of recruitment is august 2016 Current no of boys enrolled = 156 Boys can be in exon skipping trial AND FOR DMD Results expected 2018 Results will provide evidence based guidance on best steroid treatment in DMD Standardise steroid treatment Important for current and future clinical trials

Research update Starting steroids early (< age 4): Merlini et al 2012 Prolongs ambulation compared to starting steroids later. Next generation steroids: VBP15 – Dr Eric Hoffman USA Replacement drug for steroids. New drug with a similar mode of action but without side effects In addition it has been shown to stabilise the structure of muscle cells

Research update Initial results: Phase 2 (boys with DMD) Preclinical: beneficial in mice (better than prednisolone) Phase I: results awaited Phase 2 (boys with DMD) Phase 2a: In USA, steroid naïve boys Phase 2b: In Europe

Summary At the moment steroids are the only “treatment” available for all boys with DMD. The benefits are indisputable however they come at a cost. FOR DMD study: to provide an “evidence based” guidance on steroid treatment. Next generation steroids – very promising

Thank you Any questions?